We are looking for 2–17 years of age to join a CD research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or moderate to severe CD (including associated symptoms such as diarrhea with blood, abdominal cramps, abdominal pain, frequent fevers and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to take part.
